Nikita Punia, Vice President of Commerce of the Pharmasyntez Group, took part in the Pitch Session Russia – Africa: Business at the Crossroads of Opportunities, which was organized as part of the "Made in Russia" Forum in Moscow.

Exports are a crucial component of Pharmasyntez's long-term development strategy. We see great potential in African countries, where there is a growing need for affordable, high-quality medications. The company has already successfully registered and supplied products overseas, and we are ready to scale this to new markets, 

Nikita Punia stated.

15 countries, including Azerbaijan, Armenia, Belarus, Kazakhstan, Mongolia, Syria, Uzbekistan, and others, currently receive Pharmasyntez products.

As a result of the company's systematic expansion of its export geography, new registration procedures are being implemented in nations throughout the ASEAN, MENA, and LATAM regions.

We work to provide patients in various countries with access to Russian-made medications. A number of projects are already being implemented in Africa; these are countries with dynamic economic development, and we see this as a real contribution to strengthening international partnership,

the Vice President of Commerce underlined.